News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile
genosciencepharma.com
Oct 9, 2024, 16:50

Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile

Ghassan Abou-Alfa, Medical Oncologist, Memorial Sloan Kettering Cancer Center, shared a post on X:

“Congratulations and thank you Sebastian Mondaca on superb valuable effort for Chile. Memorial Sloan Kettering Cancer Center, MSK Department of Medicine, Ghassan Abou-Alfa and team are proud for contributing to ERBB2-altered gallbladder cancer characterization in Chile!”

Clinical and genomic characterization of ERBB2-altered gallbladder cancer

Authors:  Sebastian Mondaca, Nikolaus Schultz, Juan Carlos Roa, Henry S. Walch, Santiago Sepulveda, James J.              Harding, Amin Yaqubie, Patricia Garcia, Gloria Aguayo, Bruno Nervi, Bob T. Li and  Ghassan K. Abou-Alfa.

Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile

Amin Yaqubie Bob T. Li Bruno Nervi cancer cancer awareness cancer care fight against cancer Ghassan Abou-Alfa Ghassan K. Abou-Alfa Global fight against cancer Gloria Aguayo Henry S. Walch James J. Harding JCO Journal of Clinical Oncology Juan Carlos Roa Memorial Sloan Kettering Cancer Center MSK Department of Medicine Nikolaus Schultz OncoDaily Oncology Patricia Garcia Santiago Sepulveda Sebastian Mondaca
Special Coverage
Science
Feb 21, 2025, 11:03
George Vlachogiannis: A growing CRC burden among younger individuals in high socio-demographic index regions
Blog
Feb 21, 2025, 11:02
Divya Sachdev: Building a future where every child, no matter where they live, has a fair chance at survival
Blog
Feb 21, 2025, 10:55
Giuseppe Curigliano: Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology
Blog
Feb 21, 2025, 10:45
Saurabh Zanwar: Clonal plasma cell proportion in the S-phase in multiple myeloma
Blog
Feb 21, 2025, 10:37
Cihangir Akyol: A comprehensive review on colorectal ESD outcomes by Lumir Kunovsky
Celebrities
Feb 21, 2025, 10:28
In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer
Science
Feb 21, 2025, 10:07
Elai Davicioni: Predicting Dose-Response to Prostate Cancer Radiotherapy
Blog
Feb 21, 2025, 10:00
Alexios Matikas: Adjuvant endocrine treatment strategies for non-metastatic breast cancer
Blog
Feb 21, 2025, 09:58
Miriam Mutebi: February - a whirlwind of learning, collaboration, and action
Blog
Feb 21, 2025, 09:54
The publication of the European Commission Work Programme for 2025 - ESMO
Blog
Feb 21, 2025, 09:45
Michelle Kirschner: New programming at the Cancer Survivorship Provider Network
Science
Feb 21, 2025, 09:39
M. Bilal Abid: Excited to present at the UT San Antonio MD Anderson Cancer Center